Organon & (US:OGN) ZACKSยท2024-09-13 22:56Company Performance - Organon (OGN) closed at $20.47, with a daily gain of +0.89%, outperforming the S&P 500's gain of 0.54% [1] - Over the past month, Organon's shares increased by 0.35%, lagging behind the Medical sector's gain of 4.37% and the S&P 500's gain of 4.86% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with a forecasted EPS of $0.97, reflecting an 11.49% increase from the same quarter last year [2] - Revenue is projected at $1.56 billion, indicating a 2.44% rise from the equivalent quarter last year [2] Annual Estimates - For the annual period, earnings are expected to be $4.33 per share, with revenue anticipated at $6.34 billion, representing increases of +4.59% and +1.28% respectively from the previous year [3] Analyst Projections - Recent shifts in analyst projections should be monitored, as positive revisions indicate optimism regarding the company's business and profitability [4] Zacks Rank and Valuation - Organon currently holds a Zacks Rank of 4 (Sell), with the consensus EPS estimate remaining unchanged over the last 30 days [6] - The Forward P/E ratio for Organon is 4.68, significantly lower than the industry average of 22.16, and the PEG ratio stands at 0.85 compared to the industry average of 1.57 [7] Industry Context - The Medical Services industry, to which Organon belongs, has a Zacks Industry Rank of 173, placing it in the bottom 32% of over 250 industries [8]